Home

padding

padding

UC Irvine School of Medicine Reaches Semifinals of STAT Madness

Mike Johnson’s Seed Funding Fuels Researchers’ Quest to
Heal Spinal Injuries

About Us

Today’s UC Irvine Stem Cell Research Center is a dynamic center encompassing a diverse array of interdisciplinary investigators that span the schools of Medicine, Biological Sciences, Pharmacy and Pharmaceutical Sciences, Engineering, Arts, and the Program in Public Health. Our state-of-the-art, LEED Platinum certified research and clinical building houses 25 of our 65 center faculty members.    

Center faculty have obtained more than $275 million dollars in grant and foundation funds, including over $165 million dollars from the California Institute for Regenerative Medicine. Our research programs include two National Institutes of Health (NIH)-sponsored T32 training grants, NIH R25 training program, 2 CIRM training grants supporting trainees from undergraduate through to postdoctoral and clinical fellows, a NIAMS P30 skin biology research center grant, state-of-the-art shared equipment and research services cores, community lecture series, an annual stem cell science symposium, and numerous seminar series.

What can we do for you ?

Research areas, available resources and clinical trials

Learn about our clinical research and trials

Learn how you can support stem cell research at UCI

See the latest news, videos and upcoming events

News

UC Irvine-led discovery of new skeletal tissue advances regenerative medicine potential

Maksim Plikus, a UC Irvine professor, along with Raul Ramos, a postdoctoral researcher in the Plikus laboratory and the study’s lead author, says, “Lipochondrocytes are not fat cells, nor are they conventional cartilage cells. They represent cells of a distinct skeletal tissue type that uses lipids in a way we’ve never seen before.”

UC Irvine-led team discovers potential new therapeutic targets for Huntington’s disease
Findings from a study led by UC Irvine’s Thai B. Nguyen, Leslie Thompson and Robert Spitale have revealed specific patterns of RNA modifications and splicing errors unique to Huntington’s disease, potentially facilitating new approaches to treatment.
Dr. Michael Demetriou awarded $4.6 million for promising pan-cancer immunotherapy
The grant for $4,581,144 was awarded to Michael Demetriou, MD, PhD, to accelerate his lab's groundbreaking work on genetically modified chimeric antigen receptor (CAR) T cells that can destroy tumors by attacking abnormal complex sugar molecules (glycans) found on the surface of all major cancer cell types.

padding

padding

padding

Events

Community lectures, special events and opportunities to engage. Find details for future events here.

2 May.

Topic: Designer Biomaterials for Organoid Culture

Sarah Heilshorn, Ph.D.
Stanford University
Gross Hall, 4th Floor Thorp Conference Center
May 2, 2025|11:00 AM—12:00 Pm Pacific Time||In-Person Only


6 May.

Harnessing Adaptive Immunity to Promote Tissue Regeneration in Neurodegenerative Diseases
Craig Walsh, Ph.D.
Gross Hall, Thorp Conference Center
Tuesday, May 6, 2025 | 7:00 PM – 8:00PM Pacific Time

30 May.

Topic: Probing the Single-Cell Spatial Landscape of Human Skin
Andrew L Ji, MD
Associate Professor Department of Dermatology
Mouth Sinai—Icahn School of Medii-cine
Zoom Meeting or Gross Hall, Thorp Conference Center 4000
Friday, May 30, 2025 | 11:00AM—12:00PM Pacific Time

20 Jun.

Topic: Translating Hidradenitis Suppurativa Science Into Therapeutic Advances
Haley B. Naik, MD
Associate Professor Department of Dermatology
UCSF
Zoom Meeting or Gross Hall, Thorp Conference Center 4000
Friday, Jun 20, 2025 | 11:00AM—12:00PM Pacific Time